Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity

por Huynh, Kim, Klose, Marianne, Krogsgaard, Kim, Drejer, Jørgen, Byberg, Sarah, Madsbad, Sten, Magkos, Faidon, Aharaz, Abdellatif, Edsberg, Berit, Tfelt-Hansen, Jacob, Astrup, Arne Vernon, Feldt-Rasmussen, Ulla
Publicado 2022

Weight Loss, Improved Body Composition and Fat Distribution by Tesomet in Acquired Hypothalamic Obesity

por Huynh, Kim D, Klose, Marianne C, Krogsgaard, Kim, Drejer, Jorgen, Byberg, Sarah, Madsbad, Sten, Magkos, Faidon, Aharaz, Abdellatif, Edsberg, Berit, Tfelt-Hansen, Jacob, Astrup, Arne, Feldt-Rasmussen, Ulla
Publicado 2021

ODP350 Safety and Efficacy of Tesomet over 48 Weeks of Treatment: Results From a 24-Week Phase 2, Randomized, Double-Blind Study With 24 Week Open-Label Extension in Adults With Hy...

por Klose, Marianne, Huynh, Kim, Krogsgaard, Kim, Drejer, Jørgen, Pharm, Dr, Byberg, Sarah, Madsbad, Sten, Magkos, Faidon, Researcher, Senior, Aharaz, Abdellatif, Edsberg, Berit, Tfelt, Jacob, Astrup, Arne, Feldt-Rasmussen, Ulla
Publicado 2022